{
  "schema_version": "0.1.0",
  "id": "fda-drug-shortage:rifampin-capsule",
  "slug": "rifampin-capsule",
  "title": "FDA shortage status: Rifampin Capsule",
  "ingredient": "Rifampin Capsule",
  "status": "current",
  "source_statuses": [
    "Current"
  ],
  "brand_names": [
    "RIFAMPIN"
  ],
  "therapeutic_categories": [
    "Anti-Infective"
  ],
  "dosage_forms": [
    "Capsule"
  ],
  "routes": [
    "ORAL"
  ],
  "package_count": 9,
  "packages": [
    {
      "package_ndc": "42806-801-01",
      "product_ndc": "42806-799",
      "company_name": "Epic Pharma, LLC",
      "manufacturer_name": "EPIC PHARMA, LLC",
      "presentation": "Rifampin, Capsule, 150 mg (NDC 42806-801-01)",
      "availability": "Unavailable",
      "dosage_form": "Capsule",
      "routes": [
        "ORAL"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "12/22/2021",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "42806-801-30",
      "product_ndc": "42806-799",
      "company_name": "Epic Pharma, LLC",
      "manufacturer_name": "EPIC PHARMA, LLC",
      "presentation": "Rifampin, Capsule, 150 mg (NDC 42806-801-30)",
      "availability": "Available",
      "dosage_form": "Capsule",
      "routes": [
        "ORAL"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "12/22/2021",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "42806-799-01",
      "product_ndc": "42806-799",
      "company_name": "Epic Pharma, LLC",
      "manufacturer_name": "EPIC PHARMA, LLC",
      "presentation": "Rifampin, Capsule, 300 mg (NDC 42806-799-01)",
      "availability": "Unavailable",
      "dosage_form": "Capsule",
      "routes": [
        "ORAL"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "12/22/2021",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "42806-799-05",
      "product_ndc": "42806-799",
      "company_name": "Epic Pharma, LLC",
      "manufacturer_name": "EPIC PHARMA, LLC",
      "presentation": "Rifampin, Capsule, 300 mg (NDC 42806-799-05)",
      "availability": "Unavailable",
      "dosage_form": "Capsule",
      "routes": [
        "ORAL"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "12/22/2021",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "42806-799-30",
      "product_ndc": "42806-799",
      "company_name": "Epic Pharma, LLC",
      "manufacturer_name": "EPIC PHARMA, LLC",
      "presentation": "Rifampin, Capsule, 300 mg (NDC 42806-799-30)",
      "availability": "Unavailable",
      "dosage_form": "Capsule",
      "routes": [
        "ORAL"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "12/22/2021",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "42806-799-60",
      "product_ndc": "42806-799",
      "company_name": "Epic Pharma, LLC",
      "manufacturer_name": "EPIC PHARMA, LLC",
      "presentation": "Rifampin, Capsule, 300 mg (NDC 42806-799-60)",
      "availability": "Available",
      "dosage_form": "Capsule",
      "routes": [
        "ORAL"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "12/22/2021",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "68180-658-06",
      "product_ndc": "68180-658",
      "company_name": "Lupin Pharmaceuticals, Inc.",
      "manufacturer_name": "Lupin Pharmaceuticals, Inc.",
      "presentation": "Rifampin, Capsule, 150 mg (NDC 68180-658-06)",
      "availability": "Available",
      "dosage_form": "Capsule",
      "routes": [
        "ORAL"
      ],
      "update_date": "08/18/2026",
      "initial_posting_date": "12/22/2021",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "68180-659-06",
      "product_ndc": "68180-658",
      "company_name": "Lupin Pharmaceuticals, Inc.",
      "manufacturer_name": "Lupin Pharmaceuticals, Inc.",
      "presentation": "Rifampin, Capsule, 300 mg (NDC 68180-659-06)",
      "availability": "Available",
      "dosage_form": "Capsule",
      "routes": [
        "ORAL"
      ],
      "update_date": "08/18/2026",
      "initial_posting_date": "12/22/2021",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "68180-659-07",
      "product_ndc": "68180-658",
      "company_name": "Lupin Pharmaceuticals, Inc.",
      "manufacturer_name": "Lupin Pharmaceuticals, Inc.",
      "presentation": "Rifampin, Capsule, 300 mg (NDC 68180-659-07)",
      "availability": "Available",
      "dosage_form": "Capsule",
      "routes": [
        "ORAL"
      ],
      "update_date": "08/18/2026",
      "initial_posting_date": "12/22/2021",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    }
  ],
  "availability_counts": {
    "Available": 5,
    "Unavailable": 4
  },
  "initial_posting_date": "12/22/2021",
  "latest_source_update": "08/18/2026",
  "source_updated_at": "2026-08-22",
  "official_url": "https://api.fda.gov/drug/shortages.json",
  "source_name": "U.S. Food and Drug Administration openFDA Drug Shortages",
  "source_license_url": "https://open.fda.gov/license/",
  "retrieved_at": "2026-08-22T15:54:11+00:00",
  "unknowns": {
    "local_availability": "Unknown. FDA status is nationwide and is not local inventory.",
    "clinical_alternatives": "Not provided. CiteFacts does not publish treatment or substitution advice.",
    "resolution_date": "Unknown unless an FDA source row provides an update date."
  },
  "derivations": {
    "status": "current when a grouped FDA row has Current; otherwise it preserves the available FDA Resolved, Discontinuation, or not-current state.",
    "ingredient_page": "Grouped by FDA generic_name, falling back to openFDA.generic_name.",
    "availability_counts": "Count of non-empty FDA package availability values; it is not a claim about local supply."
  }
}